Review
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 21, 2023; 29(7): 1139-1156
Published online Feb 21, 2023. doi: 10.3748/wjg.v29.i7.1139
Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers
Javier Del Hoyo, Mónica Millán, Alejandro Garrido-Marín, Mariam Aguas
Javier Del Hoyo, Alejandro Garrido-Marín, Mariam Aguas, Department of Gastroenterology, La Fe University and Polytechnic Hospital, Valencia 46026, Spain
Mónica Millán, Department of Surgery, La Fe University and Polytechnic Hospital, Valencia 46026, Spain
Mariam Aguas, Health Research Institute La Fe, La Fe University and Polytechnic Hospital, Valencia 46026, Spain
Author contributions: Del Hoyo J designed the research study; Del Hoyo J and Garrido-Marín A performed the research; all authors wrote the manuscript; all authors read and approve the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mónica Millán, MD, PhD, Doctor, Staff Physician, Department of Surgery, La Fe University and Polytechnic Hospital, Av. Fernando Abril Martorell, Valencia 46026, Spain. monicamillan72@gmail.com
Received: September 21, 2022
Peer-review started: September 21, 2022
First decision: October 18, 2022
Revised: November 2, 2022
Accepted: February 9, 2023
Article in press: February 9, 2023
Published online: February 21, 2023
Core Tip

Core Tip: In this review we focus on the advances performed in telemonitoring of patients with inflammatory bowel disease, taking into consideration the elements which enabled its use and how technological achievements led to other barriers for its full implementation. We detail the impact of telemonitoring on health outcomes and its cost-effectiveness. We also describe the advances on new patient-reported outcome measures, home-based tests and wearables which improve the ability to manage new patients´ profiles remotely. However, during the pandemic, e-mail and telephone still represented the main resources used. Then, we describe the emerging barriers which explained the limited application of mature telemonitoring programs.